- Home
- BLRX vs TCBS Comparison
BLRX vs TCBS Comparison
Compare BLRX & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- TCBS
- Stock Information
- Founded
- BLRX 2003
- TCBS 1934
- Country
- BLRX Israel
- TCBS United States
- Employees
- BLRX N/A
- TCBS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- TCBS Banks
- Sector
- BLRX Health Care
- TCBS Finance
- Exchange
- BLRX Nasdaq
- TCBS Nasdaq
- Market Cap
- BLRX 15.3M
- TCBS 48.8M
- IPO Year
- BLRX 2011
- TCBS N/A
- Fundamental
- Price
- BLRX $4.52
- TCBS $16.00
- Analyst Decision
- BLRX Strong Buy
- TCBS
- Analyst Count
- BLRX 2
- TCBS 0
- Target Price
- BLRX $19.00
- TCBS N/A
- AVG Volume (30 Days)
- BLRX 64.3K
- TCBS 6.4K
- Earning Date
- BLRX 08-14-2025
- TCBS 08-12-2025
- Dividend Yield
- BLRX N/A
- TCBS 1.00%
- EPS Growth
- BLRX N/A
- TCBS N/A
- EPS
- BLRX N/A
- TCBS 0.68
- Revenue
- BLRX $22,340,000.00
- TCBS $14,488,000.00
- Revenue This Year
- BLRX N/A
- TCBS N/A
- Revenue Next Year
- BLRX N/A
- TCBS N/A
- P/E Ratio
- BLRX N/A
- TCBS $23.52
- Revenue Growth
- BLRX 91.68
- TCBS 54.08
- 52 Week Low
- BLRX $2.30
- TCBS $13.52
- 52 Week High
- BLRX $35.60
- TCBS $19.40
- Technical
- Relative Strength Index (RSI)
- BLRX 51.83
- TCBS 46.39
- Support Level
- BLRX $4.40
- TCBS $15.10
- Resistance Level
- BLRX $5.06
- TCBS $18.00
- Average True Range (ATR)
- BLRX 0.33
- TCBS 0.75
- MACD
- BLRX -0.01
- TCBS -0.04
- Stochastic Oscillator
- BLRX 54.95
- TCBS 20.93
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.